Benzinga
09 Oct 2025, 13:10 UTC · 49w ago
Verdict
Headline takes no side. We score AKRO +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
Which stocks this story touches
More positive than 98% of ticker scores this week
Acquired by Novo Nordisk for approximately $5 billion, causing a significant premarket stock price increase.
More positive than 61% of ticker scores this week
Expanding its therapeutic pipeline through the strategic acquisition of Akero Therapeutics to treat MASH.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 97% of relationship scores this week
[a_to_b] Novo Nordisk agreed to acquire Akero Therapeutics for approximately $5 billion.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2d ago
+17.6%
Price agrees with the score
$54.65 vs $46.49 close before publication (Oct 8) · not market-adjusted
AKRO chart →
